Advertisement

Topics

Destiny Pharma Ltd Company Profile

06:13 EDT 25th June 2018 | BioPortfolio

Destiny Pharma is a UK based anti-infectives pharmaceutical company founded, in 1997, by pharma industry executives. The company has developed and patented a portfolio of novel drugs that have a completely different mode of action from conventional antibiotics. These compounds (codenamed XF Drugs) have been shown to work in such a way that minimizes the development of bacterial resistance to repeated dosing. Our compounds can therefore be used to prevent and treat “superbugs” such as methicillin-resistant Staphylococcus aureus (MRSA); one of the major unmet needs of western medicine.

Location

at the Sussex Innovation Centre Science Park Square, Falmer
Brighton
BN1 9SB
United Kingdom

Contact

Phone: 44 (0) 1273 704 440
Fax: 44 (0) 1273 704 499
Email: enquiries@destiny-pharma.demon.co.uk


News Articles [751 Associated News Articles listed on BioPortfolio]

FDA accepts Destiny Pharma's IND for XF-73 clinical drug candidate

The US Food and Drug Administration (FDA) has accepted Destiny Pharma’s investigational new drug application (IND) for its anti-infective clinical drug candidate, XF-73.

Destiny Pharma's XF-73 MRSA drug gets FDA fast track designation

Destiny Pharma’s has secured fast track designation from the US Food and Drug Administration (FDA) for its lead clinical candidate exeporfinium chloride (XF-73) for the prevention of post-surgical s...

Destiny Pharma establishes Scientific Advisory Board

Destiny Pharma appoints Nick Rodgers as non-executive director

New Antibiotic for MRSA Infections is Ready for US Clinical Trials

Destiny Pharma’s antibiotic for post-surgical infections will begin its clinical development after the FDA accepted its Investigational New Drug application.  Destiny Pharma wants to combat th...

FDA accepts IND application for UK biotech’s antibacterial drug candidate

Clinical stage biotechnology company, Destiny Pharma, has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) for its lead clinical dru...

5 things medtech manufacturing executives learned from their dads

Sometimes working for your dad seems like destiny, but taking over the family business wasn't always the plan.  -More- 

You have to trust in something -- your gut, destiny, life, karma, whatever. Because believing that the dots will connect down the road will give you the confidence to follow your heart even when it leads you off the well-worn path, and that will make all

Steve Jobs, entrepreneur

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [33 Associated PubMed Articles listed on BioPortfolio]

Moving pharma contracting into the era of accountability.

Corrigendum to 'Soluble FLT-1 rules placental destiny' Biochem. Biophys. Res. Commun. 46 (2018) 1243-1249.

2018 Remington Honor Medal Address: Achieving our profession's destiny as a care provider.

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Influence without Presence: PRDM16 Casts Destiny.

Chromatin modifications play an important role in cortical neurogenesis. In this issue, Baizabal et al. (2018) show how PRDM16, a histone methyltransferase, influences upper layer neuron production a...

Clinical Trials [82 Associated Clinical Trials listed on BioPortfolio]

Diafert for Embryo Selection and Fertility Improvement (DESTINy)

Prospective, single-center, single-blind, randomized, controlled, two-arm, interventional study.

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [748 Associated Companies listed on BioPortfolio]

Destiny Pharma Ltd

Destiny Pharma is a UK based anti-infectives pharmaceutical company founded, in 1997, by pharma industry executives. The company has developed and patented a portfolio of novel drugs that have a compl...

Destiny Pharma

Destiny Pharma offers a custom research service where tailor made research studies are constructed and performed to the specific requirements of each client.Destiny Pharma specialise in:- Formulation ...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "Destiny Pharma Ltd" on BioPortfolio

We have published hundreds of Destiny Pharma Ltd news stories on BioPortfolio along with dozens of Destiny Pharma Ltd Clinical Trials and PubMed Articles about Destiny Pharma Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Destiny Pharma Ltd Companies in our database. You can also find out about relevant Destiny Pharma Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record